Icos Capsule (Icosapent ethyl) | Used for Heart and Lipid Health Support
Icos Capsule (Icosapent ethyl) is a medication used primarily to lower triglyceride levels in the blood and reduce the risk of cardiovascular events, such as heart attacks, in patients with high cholesterol.
Product Overview
Icos Capsule is a medication formulated to manage severe cholesterol imbalances and mitigate cardiovascular risks. Containing the active therapeutic compound Icosapent Ethyl, this oral capsule is an omega-3 fatty acid derivative composed entirely of the ethyl ester of eicosapentaenoic acid (EPA). Unlike standard over-the-counter fish oil supplements, Icos Capsule contains zero docosahexaenoic acid (DHA), which allows it to dramatically lower serum triglyceride levels without unintentionally elevating low-density lipoprotein (LDL, or "bad") cholesterol. It is prescribed as an essential adjunct to dietary modifications and maximally tolerated statin therapies for individuals at high risk of cardiac events.
Product Composition
- Active Pharmaceutical Ingredient: Icosapent Ethyl (typically formulated at 0.5g & 1 gram per soft gelatin capsule)
- Dosage Form: Oval, transparent soft gelatin capsules containing a clear, amber-colored liquid oil
- Core Excipients: Contains the purified active oil encapsulated within a gelatin shell consisting of glycerin, sorbitol, and purified water, often stabilized with a small trace of alpha-tocopherol (Vitamin E) as an antioxidant
Product Specification
| Product Parameter | Details |
| Brand Name | Icos Capsule |
| Active Ingredient | Icosapent Ethyl |
| Therapeutic Class | Cardiovascular Agents / Antihyperlipidemics (Omega-3 Fatty Acids) |
| Available Strength | 0.5g & 1g |
| Primary Indications | Severe hypertriglyceridemia, and cardiovascular risk reduction in patients with elevated triglycerides |
Mechanism of Action
- Hepatic VLDL Synthesis Inhibition: Icosapent ethyl functions by inhibiting critical acyl-coenzyme A:1,2-diacylglycerol acyltransferase (DGAT) enzymes within the liver, which significantly reduces the hepatic synthesis and secretion of Very-Low-Density Lipoproteins (VLDL) and triglycerides.
- Fatty Acid Beta-Oxidation Enhancement: It upregulates mitochondrial and peroxisomal beta-oxidation pathways in hepatic tissues, increasing the rate at which the body breaks down circulating fatty acids.
- Lipoprotein Lipase Stimulation: The drug enhances the clearance of triglycerides from circulating blood plasma by stimulating the activity of peripheral lipoprotein lipase (LPL) enzymes.
- Anti-Inflammatory and Plaque Stabilization: As a pure EPA formulation, it exerts systemic anti-inflammatory, anti-aggregatory, and endothelial-stabilizing effects, helping to reduce the overall progression and vulnerability of atherosclerotic plaques.
Key Benefits
- Significantly lowers extremely high fasting triglyceride concentrations without causing a secondary rise in circulating LDL cholesterol levels.
- Demonstrates proven clinical efficacy in reducing the overall risk of stroke, myocardial infarction (heart attack), and coronary revascularization procedures in high-risk patients.
- Provides a highly purified, standardized dose of prescription-grade EPA, eliminating the impurities, saturated fats, and variable concentrations found in unregulated commercial fish oils.
- Exhibits excellent long-term tolerability when added to standard, daily background statin regimens for comprehensive lipid management.
Usage
This prescription-strength lipid-regulating agent must be used consistently alongside a heart-healthy diet and a regular exercise program. To achieve the best therapeutic outcomes, the daily dosage should be maintained exactly as prescribed by a physician. Because this medication can alter blood parameters, patients should undergo periodic blood tests to evaluate liver function and monitor lipid profiles before and during long-term therapy.
| Parameter | Clinical Guidelines |
| Standard Dosage | The standard clinical adult dose is 4 grams daily, administered as two 1-gram capsules taken twice per day. Do not alter or reduce the dose without direct medical guidance. |
| Administration Route | For oral use only. Capsules must be swallowed whole and should never be broken, crushed, dissolved, or chewed, as this can affect the controlled release of the active oil. |
| Dietary Pairing | Must be taken with or immediately after a meal. Pairing the medication with food significantly enhances gastrointestinal absorption and minimizes minor digestive issues. |
| Monitoring and Interactions | Patients with a history of irregular heart rhythms should have their pulse monitored. Those taking concurrent blood thinners require regular coagulation tests due to an increased risk of bruising or bleeding. |
Uses
Reduction of Cardiovascular Risk: Indicated as an adjunctive therapy to reduce the risk of myocardial infarction (heart attack), stroke, coronary revascularization, and unstable angina requiring hospitalization in adult patients. This applies to individuals with elevated triglyceride levels who have established cardiovascular disease or diabetes mellitus accompanied by two or more cardiovascular risk factors.
Management of Severe Hypertriglyceridemia: Prescribed as an adjunct to a comprehensive low-fat, low-cholesterol diet to reduce severely elevated serum triglyceride concentrations in adult patients.
Prevention of Atherosclerotic Plaque Progression: Utilized in high-risk patients to help stabilize vascular endothelial walls and prevent the systemic maturation and vulnerability of arterial plaques, lowering the potential for acute vessel blockages.
Targeted Statin-Adjunct Therapy: Employed specifically as a combination agent alongside maximally tolerated statin therapy to address residual cardiovascular risks that remain unresolved by standard cholesterol-lowering treatments alone.
FAQs
Q: What is Icos Capsule used for?
A: This prescription-strength omega-3 fatty acid medication is used to lower severely elevated triglyceride levels in the blood. It is also prescribed to reduce the risk of major cardiovascular events, including heart attacks, strokes, and the need for heart surgery in high-risk patients.
Q: How does Icos Capsule differ from over-the-counter fish oil supplements?
A: Unlike retail fish oil supplements which contain a mix of EPA and DHA, this medication is a highly purified form of pure icosapent ethyl (an EPA ethyl ester) with zero DHA. This composition is essential because DHA can accidentally raise LDL ("bad") cholesterol, whereas pure EPA drives down triglycerides without impacting LDL levels.
Q: How should this lipid-regulating medication be taken?
A: The typical clinical dose is 4 grams per day, commonly split as two 1-gram capsules taken twice daily. The capsules must be swallowed whole with food or directly after a meal to optimize gastrointestinal absorption and minimize minor digestive side effects.
Q: Can Icos Capsules increase the risk of bleeding?
A: Yes, high doses of pure eicosapentaenoic acid (EPA) can prolong bleeding time. The risk of bruising or bleeding increases if the patient takes this medication concurrently with antithrombotic drugs, blood thinners, or antiplatelet therapies like aspirin, clopidogrel, or warfarin.
Q: What is the risk regarding Atrial Fibrillation?
A: Clinical evidence shows that icosapent ethyl is associated with an increased risk of atrial fibrillation or atrial flutter requiring hospitalization. This risk is notably higher in individuals with a medical history of irregular heart rhythms, and patients should report any palpitations or dizziness immediately.
Q: Is it safe for individuals with a fish or shellfish allergy?
A: Because the active drug is derived directly from highly purified fish oil, it should be used with extreme caution in anyone with a known hypersensitivity to fish or shellfish. If any signs of an allergic reaction occur, such as a rash, hives, or breathing difficulties, the medication must be discontinued.
Interactions
Drug Interactions of Icos Capsule (Icosapent Ethyl)
Icos Capsule may interact with medicines that affect blood clotting or heart health. Inform about all ongoing medicines before use.
| Medicine or Product Type | Interaction Details |
|---|---|
| Blood Thinners | May increase bleeding risk. |
| Antiplatelet Medicines | Can increase bleeding tendency. |
| Cholesterol Medicines | Usually used together with monitoring. |
| Blood Pressure Medicines | Monitor treatment response. |
| Herbal Supplements | Some may affect bleeding risk. |
| Omega 3 Supplements | May increase similar effects. |
Important Interaction Advice
- Inform about all blood thinning medicines
- Avoid unnecessary omega 3 supplements together
- Monitor for unusual bruising or bleeding
- Do not stop heart medicines without advice
General Guidance
- Regular blood and lipid monitoring may be needed
- Combination therapy is often used for lipid control
- Report bleeding, dizziness, or irregular heartbeat
- Maintain follow-up during treatment
Additional Note
- Always share complete medication history before starting Icos Capsule to reduce interaction risks
| Manufacturer | : | Dr. Reddy Lab, India |
| Trade Name | : | Vascepa |
| Generic Search | : | Icosapent ethyl |
| Strength | : | 500mg, 1000mg |
Latest Products
